185 related articles for article (PubMed ID: 17658412)
1. Quality control in clinical flow cytometry.
Oldaker TA
Clin Lab Med; 2007 Sep; 27(3):671-85, viii. PubMed ID: 17658412
[TBL] [Abstract][Full Text] [Related]
2. Quality control in flow cytometry for diagnostic pathology: II. A conspectus of reference ranges for lymphocyte immunophenotyping.
McCoy JP; Overton WR
Cytometry; 1994 Sep; 18(3):129-39. PubMed ID: 7813333
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study of reference stabilized human blood for lymphocyte immunophenotyping quality control in flow cytometry. GEIL.
Baudouin F; Sarda MN; Goguel A; Béné MC
Cytometry; 1999 Jun; 38(3):127-32. PubMed ID: 10397332
[TBL] [Abstract][Full Text] [Related]
4. [Standardization in flow cytometry].
Tatsumi N; Kitahashi S; Kubota H; Tsuda I; Yasui Y; Tanaka K; Kondo H
Rinsho Byori; 1993 Sep; 41(9):982-9. PubMed ID: 8254976
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric lymphocyte subset enumeration: 10 years of external quality assessment in the Benelux countries.
Levering WH; van Wieringen WN; Kraan J; van Beers WA; Sintnicolaas K; van Rhenen DJ; Gratama JW
Cytometry B Clin Cytom; 2008 Mar; 74(2):79-90. PubMed ID: 17849485
[TBL] [Abstract][Full Text] [Related]
6. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189
[TBL] [Abstract][Full Text] [Related]
7. Impact of standardization on clinical cell analysis by flow cytometry.
Keeney M; Barnett D; Gratama JW
J Biol Regul Homeost Agents; 2004; 18(3-4):305-12. PubMed ID: 15786697
[TBL] [Abstract][Full Text] [Related]
8. Issues for quality assurance in clinical flow cytometry.
McCarthy RC; Fetterhoff TJ
Arch Pathol Lab Med; 1989 Jun; 113(6):658-66. PubMed ID: 2658909
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of flow cytometry in hematology and immunology.
McCurley TL; Larson R
Clin Lab Sci; 1996; 9(6):358-62. PubMed ID: 10165118
[TBL] [Abstract][Full Text] [Related]
10. Quality Control of Immunophenotyping.
Greig B
Methods Mol Biol; 2019; 2032():227-279. PubMed ID: 31522423
[TBL] [Abstract][Full Text] [Related]
11. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.
Bromberg JE; Breems DA; Kraan J; Bikker G; van der Holt B; Smitt PS; van den Bent MJ; van't Veer M; Gratama JW
Neurology; 2007 May; 68(20):1674-9. PubMed ID: 17502548
[TBL] [Abstract][Full Text] [Related]
12. Quantitative identification of blood cell markers in human hematopoietic malignancies with diagnostic and prognostic significance.
Kusenda J
Neoplasma; 2008; 55(5):381-6. PubMed ID: 18665747
[TBL] [Abstract][Full Text] [Related]
13. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics.
Nicholson JK
Eur J Histochem; 1994; 38 Suppl 1():7-12. PubMed ID: 8547714
[TBL] [Abstract][Full Text] [Related]
14. Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience.
Solly F; Angelot-Delettre F; Ticchioni M; Geneviève F; Rambaud H; Baseggio L; Plesa A; Debliquis A; Garnache-Ottou F; Roggy A; Campos L; Aanei C; Rosenthal-Allieri A; Georget MT; Lachot S; Jacob MC; Robillard N; Wuilleme S; Andre-Kerneis E; Cornet E; Salaun V; Bennami H; Lhoumeau AC; Arnoulet C; Jacqmin H; Neyman N; Latger-Cannard V; Massin F; Lainey E; Le Garff-Tavernier M; Costopoulos M; Roussel M; Mayeur-Rousse C; Eischen A; Raggeneau V; Derrieux C; Maurer M; Asnafi V; Trinquand A; Brouzes C; Lhermitte L
Cytometry A; 2019 Sep; 95(9):1008-1018. PubMed ID: 31364809
[TBL] [Abstract][Full Text] [Related]
15. Survey of quality assurance/quality control practices for CD4+ lymphocyte counting.
Koepke JA
Cytometry; 1996 Jun; 26(2):178-80. PubMed ID: 8817096
[No Abstract] [Full Text] [Related]
16. Flow cytometry and cytomorphology evaluation of hematologic malignancy in cerebrospinal fluids: comparison with retrospective clinical outcome.
Cesana C; Klersy C; Scarpati B; Brando B; Faleri M; Bertani G; Gatti A; Volpato E; Barba C; Ferri U; Scampini L; Grillo G; Lando G; Nosari A; Morra E; Cairoli R
Ann Hematol; 2011 Jul; 90(7):827-35. PubMed ID: 21212952
[TBL] [Abstract][Full Text] [Related]
17. Long-term stabilized blood samples as controls for flow cytometric HLA-B27 screening: a feasibility study.
Levering WH; Wind H; Granger V; Sintnicolaas K; Hooijkaas H; Reilly JT; Gratama JW; Barnett D
Cytometry B Clin Cytom; 2008 May; 74(3):169-81. PubMed ID: 18200592
[TBL] [Abstract][Full Text] [Related]
18. Quality control in flow cytometry for diagnostic pathology. I. Cell surface phenotyping and general laboratory procedures.
McCoy JP; Carey JL; Krause JR
Am J Clin Pathol; 1990 Apr; 93(4 Suppl 1):S27-37. PubMed ID: 1690504
[TBL] [Abstract][Full Text] [Related]
19. [Immunophenotyping of haematologic malignancies].
Koehorst SG; Evers H; van Buul T; de Vries F; Haanen C
Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1861-5. PubMed ID: 15497779
[TBL] [Abstract][Full Text] [Related]
20. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications.
Davis BH; Holden JT; Bene MC; Borowitz MJ; Braylan RC; Cornfield D; Gorczyca W; Lee R; Maiese R; Orfao A; Wells D; Wood BL; Stetler-Stevenson M
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S5-13. PubMed ID: 17803188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
